Has Bhavi Khant received payments from drug or device companies?

Yes. Drug and device makers reported $530 in general payments to Bhavi Khant across 23 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bhavi Khant did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bhavi Khant come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bhavi Khant

Family · Bensalem, PANPI 1619629748

Payments from drug & device makers

$530in general payments, 2019–2025

Across 23 payments — averaging $23.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$91
Almirall LLC$72
Sun Pharmaceutical Industries Inc.$70
Pfizer$62
AbbVie$58
Sanofi$55
plus $122 from 4 others

What the payments were for

Food & beverage$51597%
Education$153%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	4	$91
Almirall LLC	2	$72
Sun Pharmaceutical Industries Inc.	3	$70
Pfizer	3	$62
AbbVie	3	$58
Sanofi	2	$55
Regeneron Healthcare Solutions, Inc.	1	$39
E.r. Squibb & Sons, L.L.C.	2	$34
Organon	2	$27
Johnson & Johnson	1	$22

How this compares

$530 in reported general payments places this provider in the 60th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$164,709

Medicare patients

495

Services billed

2,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	115	$3,400
Metronidazole	40	$2,734
Ketoconazole	113	$1,672
Triamcinolone Acetonide	160	$1,405
Doxycycline Monohydrate	82	$1,156
Mupirocin	164	$1,008
Fluocinonide	27	$752
Ciclopirox	24	$684
Clindamycin Phosphate	26	$598
Hydrocortisone	93	$486
Nystatin	46	$335
Ammonium Lactate	12	$230
Mometasone Furoate	12	$0

Paid to pharmacies, not to this prescriber.

Other family in Bensalem

Kathleen ScholzPittsburgh$397K
Shannon FitzgeraldAllison Park$370K
Stephanie HarshbargerCamp Hill$317K
Whitney BowlesFort Washington$253K
Kweilynn GreenePittsburgh$139K
Jessica LindenbergerPittsburgh$131K
Kami NestlerWilkes Barre$129K
Bethany ThomasPhiladelphia$126K
Margaret RosenzweigPittsburgh$89K
Amanda GrippoDickson Cty$86K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →